A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.
May 02, 2012
May 01, 2012
In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.
April 23, 2012
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted — in fact, it is dramatically underutilized according to a new UCSF study.
April 19, 2012
In honor of National Skin Cancer Awareness Month, the UCSF Department of Dermatology is offering free skin cancer screenings. The event is co-sponsored by Assemblyman Tom Ammiano, and San Francisco Supervisor Christina Olague.
April 17, 2012
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
April 02, 2012
Frank McCormick, director of the Helen Diller Family Comprehensive Cancer Center at UCSF and new president of the 35,000-member American Association of Cancer Research, discusses the state of cancer research.
March 26, 2012
Long considered a New Age way of meditating and exercising, yoga, qigong and tai chi have increasingly become popular among cancer patients who regain strength and balance after chemotherapy and surgery.
March 05, 2012
Feng-Yen Li, a PhD candidate in biomedical sciences at UCSF, is among 13 graduate students from throughout North America chosen to receive the 2012 Harold M. Weintraub Graduate Student Award.
February 24, 2012
Simultaneous targeting of two different molecules in cancer is an effective way to shrink tumors, block invasion, and stop metastasis, scientists at UCSF have found — work that may improve the effectiveness of combination treatments that include drugs like Avastin.
February 22, 2012
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at UCSF have discovered how a protein “master regulator” goes awry, leading to metastasis, the fatal step of cancer.